文献速递乳腺癌

乳腺癌后活产女性的生存:诊断年龄与后续妊娠间隔的影响

Survival after breast cancer in women with a subsequent live birth: Influence of age at diagnosis and interval to subsequent pregnancy.
PubMed 文献 · Eur J Cancer · 2022-07-19

基于苏格兰癌症登记与产科记录,分析1981至2017年20-39岁确诊乳腺癌的5181例女性,其中290例确诊后有活产。匹配未活产对照后,活产者总生存提高(HR 0.65,95%CI 0.50-0.85),年轻及既往未妊娠者获益更明显,ER状态及化疗暴露亚组结果相似。

要点

  • 乳腺癌后活产者总生存优于无活产者,HR 0.65(95%CI 0.50-0.85)。
  • 诊断年龄20-25岁者活产与生存交互更强,HR 0.30(95%CI 0.12-0.74)。
  • ER阳性与阴性、已知化疗暴露者中活产与生存关联相似。

核心结论

  • 分析进一步表明,乳腺癌后活产对总生存无负面影响,该发现在最年轻女性和既往未妊娠者等亚组中得到确认。

研究设计与样本

  • 基于苏格兰癌症登记与国家产科记录,分析1981至2017年20-39岁确诊乳腺癌的全国队列女性5181例。
  • 290例确诊后至少一次活产者,每例按保证时间偏倚匹配最多6例无后续活产的未暴露对照。

主要发现

  • 290例确诊后活产女性总生存较无后续活产者提高,HR 0.65(95%CI 0.50-0.85)。
  • 乳腺癌前未妊娠且后续活产者生存提高,HR 0.56(95%CI 0.38-0.82)。
  • 后续活产与生存的交互随年龄减小而增强,20-25岁HR 0.30(95%CI 0.12-0.74),36-39岁HR 0.89(95%CI 0.42-1.87)。
  • 诊断后五年内活产者生存亦提高,HR 0.66(95%CI 0.49-0.89)。
  • 按ER状态(阳性与阴性)及已知化疗暴露者中,活产后生存与未暴露女性相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There remains a considerable concern among both patients and oncologists that having a live birth (LB) after breast cancer might adversely impact survival. METHODS: analysis of survival in a national cohort of women with breast cancer diagnosed at age 20-39 years between 1981 and 2017 (n = 5181), and subsequent LB using Scottish Cancer Registry and national maternity records. Cases had at least one subsequent LB, each was matched with up to six unexposed cases without subsequent LB, accounting for guaranteed time bias. RESULTS: In 290 women with a LB after diagnosis, overall survival was increased compared to those who did not have a subsequent LB, HR 0.65 (95%CI 0.50-0.85). Women with subsequent LB who had not had a pregnancy before breast cancer showed increased survival (HR 0.56, 0.38-0.82). There was a progressively greater interaction of subsequent LB with survival with younger age, thus for women aged 20-25 years, HR 0.30 (0.12-0.74) vs. those aged 36-39, HR 0.89 (0.42-1.87). In women with LB within five years of diagnosis, survival was also increased (HR 0.66; 0.49-0.89). Survival following LB was similar to unexposed women by ER status (both positive and negative) and in those known to have been exposed to chemotherapy. CONCLUSIONS: This analysis provides further evidence that for the growing number of women who wish to have children after breast cancer, LB does not have a negative impact on overall survival. This finding was confirmed within subgroups, including the youngest women and those not previously pregnant.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Anderson RA, Lambertini M, Hall PS, et al. Survival after breast cancer in women with a subsequent live birth: Influence of age at diagnosis and interval to subsequent pregnancy. Eur J Cancer. 2022. PMID: 35868140. doi:10.1016/j.ejca.2022.06.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。